Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis-Reference-Cited by-同舟云学术

Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis

Published:2001-06-01 Issue:6 Volume:47 Page:525-531
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:
Short-container-title:Cancer Chemotherapy and Pharmacology

Author:

Budman Daniel,Johnson Robert,Barile Barbara,Bowsher Ronald,Vinciguerra Vincent,Allen Steven,Kolitz Jonathan,Ernest Steven,Kreis Willi,Zervos Peter,Walling Jackie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s002800000272.pdf

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer;Cancer Chemotherapy and Pharmacology;2017-11-10

2. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2- d ] pyrimidine analogues as antifolate antitumor agents;European Journal of Medicinal Chemistry;2017-09

3. Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis;Journal of Medicinal Chemistry;2016-08-26

4. Structural and Enzymatic Analysis of Tumor-Targeted Antifolates That Inhibit Glycinamide Ribonucleotide Formyltransferase;Biochemistry;2016-08-03

5. Targeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]Pyrimidine Thienoyl Antifolates;Molecular Pharmacology;2016-02-02